Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented

Generic Name: dry idea advanced dry roll-on antiperspirant and deodorant unscented

Over-the-Counter (OTC)

Brand Names:

Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented

OTC Purpose

Overview

OTC Purpose

Uses

Indications & Usage

Dosage

Dosage & Administration

Side Effects

OTC-Stop Use Section

Warnings

Warnings

Frequently Asked Questions

What is Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented used for?

Indications & Usage

What are the side effects of Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented?

OTC-Stop Use Section

What are the important warnings for Dry Idea Advanced Dry Roll-on Antiperspirant And Deodorant Unscented?

Warnings

Related Medications

Red Maple

red maple

Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ACER RUBRUM POLLEN (.05 g/mL). Category: BLA.

Foeniculum Vulgare, Ammonium Bromatum, Fucus Vesiculosus, Lecithin, Rutinic Acid, Iodium, Capsicum Annuum, Galium Aparine, Hypothalamus Suis, Kali Bichromicum, Lac Defloratum, Phytolacca Decandra, Spongia Tosta, Thyroidinum (bovine), Pituitarum Posterium (bovine), Antimonium Crudum, Argentum Metallicum, Calcarea Carbonica, Adrenalinum, Phosphorus, Lapis Albus

foeniculum vulgare, ammonium bromatum, fucus vesiculosus, lecithin, rutinic acid, iodium, capsicum annuum, galium aparine, hypothalamus suis, kali bichromicum, lac defloratum, phytolacca decandra, spongia tosta, thyroidinum (bovine), pituitarum posterium (bovine), antimonium crudum, argentum metallicum, calcarea carbonica, adrenalinum, phosphorus, lapis albus

Non-Standardized Plant Allergenic Extract [EPC]

PURPOSE: Appetite suppressant to control empty feeling in stomach otherwise relieved by eating. Helps with metabolic tendencies to gain weight, helps to suppress cravings. Aids in mobilization of fatty tissue, resets the hypothalamus and provides thyroid support.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Tarlatamab-dlle

tarlatamab-dlle

11 DESCRIPTION Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dlle is produced using recombinant DNA technology in Chinese hamster ovary cells. It consists of 982 amino acids and has a molecular weight of approximately 105 kilodaltons.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.